Prevalence of polyomaviruses and links with human diseases

Future Virology

Volumn 6, Issue 10, 2011, Pages 1187-1197

  Nicol, Jérme T J ^a   Touzé, Antoine ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

BKPyV; HPyV6; HPyV7; HPyV9; immunosuppression; JCPyV; KIPyV; MCPyV; Merkel cell carcinoma; Polyomaviridae; seroepidemiology; SV40; TSPyV; WUPyV

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; NATALIZUMAB; POLIOMYELITIS VACCINE; PROTEIN VP1; VIRUS DNA; VIRUS T ANTIGEN;

ANTIVIRAL THERAPY; ATROPHY; BK VIRUS; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; COLORECTAL TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN POLYOMAVIRUS 6; HUMAN POLYOMAVIRUS 7; HUMAN POLYOMAVIRUS 9; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; JC VIRUS; KI POLYOMAVIRUS; KIDNEY CELL; KIDNEY DISEASE; KIDNEY NECROSIS; KIDNEY TRANSPLANTATION; LEUKEMIA; LUNG TUMOR; LYMPHOMA; LYMPHOTROPIC POLYOMAVIRUS; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MESOTHELIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; POLYOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RESPIRATORY TRACT TUMOR; REVIEW; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; SIMIAN VIRUS 40; SKIN DISEASE; SOUTHERN BLOTTING; TRICHODYSPLASIA SPINULOSA; UPPER RESPIRATORY TRACT INFECTION; URETER OBSTRUCTION; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; WU POLYOMAVIRUS;

BK POLYOMAVIRUS; JC POLYOMAVIRUS; MURINAE; POLYOMAVIRIDAE; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 80054748412     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.11.96     Document Type: Review

References (98)

1. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 83, 414-421 (1953).
2. Sweet BH, Hilleman MR. The vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 105, 420-427 (1960).
3. Minor P, Pipkin PA, Cutler K, Dunn G. Natural infection and transmission of SV40. Virology 314, 403-409 (2003). (Pubitemid 37153325)
4. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1(7712), 1253-1257 (1971).
5. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257-1260 (1971).
6. Allander T, Andreasson K, Gupta S et al. Identification of a third human polyomavirus. J. Virol. 81, 4130-4136 (2007). (Pubitemid 46586907)
7. Gaynor AM, Nissen MD, Whiley DM et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 3, E64 (2007).
8. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319, 1096-1100 (2008). (Pubitemid 351300792)
9. Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7, 509-515 (2010).
10. van der Meijden E, Janssens RWA, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MCW. Discovery of a new human polyomavirus associated with Trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 6, E1001024 (2010).
11. Scuda N, Hofmann J, Calvignac-Spencer S et al. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J. Virol. 85, 4586-4590 (2011).
12. Johne R, Buck CB, Allander T et al. Taxonomical developments in the family Polyomaviridae. Arch. Virol. 156(9), 1627-1634 (2011).
13. Gjoerup O, Chang Y. Update on human polyomaviruses and cancer. Adv. Cancer Res. 106, 1-51 (2010).
14. Diamandopoulos GT. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176, 173-175 (1972).
15. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am. J. Pathol. 142, 1524-1533 (1993). (Pubitemid 24058139)
16. Todaro GJ, Takemoto KK. "Rescued" SV40: increased transforming efficiency in mouse and human cells. Proc. Natl Acad. Sci. USA 62, 1031-1037 (1969).
17. Carbone M, Pass HI, Rizzo P, Marinetti M et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9, 1781-1790 (1994). (Pubitemid 24163409)
18. Lednicky JA, Stewart AR, Jenkins JJ 3rd, Finegold MJ, Butel JS. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int. J. Cancer 72, 791-800 (1997). (Pubitemid 27431522)
19. Martini F, Iaccheri L, Lazzarin L et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res. 56, 4820-4825 (1996). (Pubitemid 26338090)
20. Vilchez RA, Madden CR, Kozinetz CA et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 359, 817-823 (2002). (Pubitemid 34233750)
21. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl Cancer Inst. 91, 119-134 (1999). (Pubitemid 29042689)
22. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plas-mids. Lancet 364, 1157-1166 (2004). (Pubitemid 39296603)
23. Rollison DE, Utaipat U, Ryschkewitsch C et al. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int. J. Cancer 113, 769-774 (2005). (Pubitemid 40101258)
24. Rizzo P, Carbone M, Fisher SG et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 116, 470S-473S (1999). (Pubitemid 30013160)
25. Shah KV. SV40 and human cancer: a review of recent data. Int. J. Cancer 120, 215-223 (2007). (Pubitemid 44956830)
26. Engels EA, Katki HA, Nielsen NM et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J. Natl Cancer Inst. 95, 532-539 (2003). (Pubitemid 36511624)
27. Sanjose S de, Shah KV, Domingo- Domenech E et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. International journal of cancer Int. J. Cancer 104, 522-524 (2003). (Pubitemid 36323925)
28. Carter JJ, Madeleine MM, Wipf GC et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl Cancer Inst. 95, 1522-1530 (2003). (Pubitemid 37322095)
29. Egli A, Infanti L, Dumoulin A et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis 199, 837-846 (2009).
30. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J. Med. Virol. 10, 91-99 (1982). (Pubitemid 12030800)
31. Sundsfjord A, Spein AR, Lucht E, Flaegstad T, Seternes OM, Traavik T. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J. Clin. Microbiol. 32, 1390-1394 (1994). (Pubitemid 24132587)
32. Ahmed W, Wan C, Goonetilleke A GT. Evaluating sewage-associated JCV and BKV polyomaviruses for sourcing human fecal pollution in a coastal river in Southeast Queensland, Australia. J. Environ. Qual. 39, 1743-1750 (2010).
33. Roingeard P, Al-Najjar A, Buchler M, Goudeau A, Lebranchu Y. Infection par le virus BK chez un transplanté rénal (Cas-image). Virologie 3, 418-419 (1999).
34. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am. J. Transplant. 8, 1926-1933 (2005). (Pubitemid 41039867)
35. Egli A, Binggeli S, Bodaghi S et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol. Dial. Transplant. 22, VIII72-VIII82 (2007).
36. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347, 488-496 (2002). (Pubitemid 34879336)
37. Lamoth F, Pascual M, Erard V, Venetz JP, Nseir G, Meylan P. Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. Antivir. Ther. 13, 1001-1009 (2008).
38. Bodaghi S, Comoli P, B'sch R, Azzi A et al. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J. Clin. Microbiol. 47, 2577-2585 (2009).
39. Weber T, Major EO. Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 40, 98-111 (1997). (Pubitemid 28021604)
40. Khalili K, White MK. Human demyelinating disease and the polyomavirus JCV. Mult. Scler. 12, 133-142 (2006).
41. Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR. Progressive multifocal leukoencephalopathy in transplant recipients. Transpl. Int. 17, 658-665 (2005). (Pubitemid 40558222)
42. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon b-1a for multiple sclerosis. N. Engl. J. Med. 353, 369-374 (2005). (Pubitemid 41132341)
43. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353, 375-381 (2005). (Pubitemid 41132342)
44. Van Assche G, Van Ranst M, Sciot R et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 353, 362-368 (2005). (Pubitemid 41132340)
45. Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 61, 35-47 (2010).
46. Richardson-Burns SM, Kleinschmidt-DeMasters BK, DeBiasi RL, Tyler KL. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch. Neurol. 59, 1930-1936 (2002). (Pubitemid 35424652)
47. Zu Rheim GM, Varakis JN. Perinatal induction of medulloblastomas in Syrian golden hamster by a human polyomavirus (JC). Natl Cancer Inst. Monogr. 51, 205-208 (1979). (Pubitemid 9239339)
48. Das D, Wojno K, Imperiale MJ. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J. Virol. 82, 2705-2714 (2008). (Pubitemid 351329162)
49. Casini B, Borgese L, Del Nonno F et al. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. AntiCancer Res. 25, 1079-1085 (2005). (Pubitemid 40546884)
50. Maginnis MS, Atwood WJ. JC virus: an oncogenic virus in animals and humans? Semin. Cancer Biol. 19, 261-269 (2009).
51. Fioriti D, Videtta M, Mischitelli M et al. The human polyomavirus BK: potential role in cancer. J. Cell. Physiol. 204, 402-406 (2005). (Pubitemid 40934633)
52. Csoma E, Mészáros B, Asztalos L, Kónya J, Gergely L. Prevalence of WU and KI polyomaviruses in plasma, urine, and respiratory samples from renal transplant patients. J. Med. Virol. 83, 1275-1278 (2011).
53. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathol. 5, E1000363 (2009).
54. Babakir-Mina M, Ciccozzi M, Alteri C et al. Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J. Med. Virol. 81, 1668-1673 (2009).
55. Babakir-Mina M, Ciccozzi M, Farchi F et al. KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy. Emerg. Infect. Dis 16, 1482-1485 (2010).
56. Foulongne V, Brieu N, Jeziorski E, Chatain A, Rodire M, Segondy M. KI and WU polyomaviruses in children, France. Emerg. Infect. Dis 14, 523-525 (2008).
57. Mourez T, Bergeron A, Ribaud P et al. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg. Infect. Dis 15, 107-109 (2009).
58. Norja P, Ubillos I, Templeton K, Simmonds P. No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J. Clin. Virol. 40, 307-311 (2007). (Pubitemid 350152006)
59. Babakir-Mina M, Ciccozzi M, Bonifacio D et al. Identification of the novel KI and WU polyomaviruses in human tonsils. J. Clin. Virol. 46, 75-79 (2009).
60. Babakir-Mina M, Ciccozzi M, Campitelli L et al. Identification of the novel KI Polyomavirus in paranasal and lung tissues. J. Med. Virol. 81, 558-561 (2009).
61. Giraud G, Ramqvist T, Pastrana DV et al. DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas. PloS One 4, E8239 (2009).
62. Toker C. Trabecular carcinoma of the skin. Arch. Dermatol. 105, 107-110 (1972).
63. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J. Cutan. Pathol. 37, 20-27 (2010).
64. Boccara O, Girard C, Mortier L, Bens G, Saiag P, Guillot B. Guidelines for the diagnosis and treatment of Merkel cell carcinoma. Ann. Dermatol. Venereol. 138, 475-482 (2011).
65. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J. Surg. Oncol. 89, 1-4 (2005). (Pubitemid 40075960)
66. Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of merkel cell carcinoma. Curr. Probl. Cancer 34, 14-37 (2010).
67. Shaw M, Warren S, Groben P, Gulley ML. No evidence of Epstein-Barr virus association with Merkel cell carcinoma. J. Cutan. Pathol. 33, 624-628 (2006). (Pubitemid 44370060)
68. Kanitakis J, Joly MO, Chouvet B, Euvrard S, Claudy A. Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPV. Eur. J. Dermatol. 16, 445-6 (2006). (Pubitemid 44328994)
69. Feng H, Taylor JL, Benos PV et al. Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J. Virol. 81, 11332-11340 (2007). (Pubitemid 47536104)
70. Touzé A, Gaitan J, Maruani A et al. Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg. Infect. Dis 15, 960-962 (2009).
71. Paulson KG, Lemos BD, Feng B et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J. Invest. Dermatol. 129, 1547-1555 (2009).
72. Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, Toland AE. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J. Invest. Dermatol. 129, 2868-2874 (2009).
73. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, Nghiem P. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J. Invest. Dermatol. 129, 246-248 (2009).
74. Foulongne V, Courgnaud V, Champeau W, Segondy M. Detection of Merkel cell polyomavirus on environmental surfaces. J. Med. Virol. 83, 1435-1439 (2011).
75. Sastre-Garau X, Peter M, Avril M-F et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol. 218, 48-56 (2009).
76. Vaccarella S, Franceschi S, Clifford GM et al. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev. 19, 2379-2388 (2010).
77. Feng H, Kwun HJ, Liu X et al. Cellular and viral factors regulating Merkel cell polyomavirus replication. PloS One 6, E22468 (2011).
78. Touzé A, Gaitan J, Arnold F et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J. Clin. Microbio. 48, 1767-1770 (2010).
79. Tolstov YL, Pastrana DV, Feng H et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 125, 1250-1256 (2009).
80. Carter JJ, Paulson KG, Wipf GC et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J. Natl Cancer Inst. 101, 1510-1522 (2009).
81. Chen T, Hedman L, Mattila PS et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J. Clin. Virol. 50, 125-129 (2011).
82. Touzé A, Le Bidre E, Laude H et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J. Clin. Oncol. 29, 1612-1619 (2011).
83. Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H. Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med. Microbiol. Immunol. doi: 10.1007/s00430-011-0200-7 (2011) (Epub ahead of print).
84. Faust H, Pastrana DV, Buck CB, Dillner J, Ekstrm J. Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin. J. Infect. Dis 203, 1096-1100 (2011).
85. Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathol. 5, E1000578 (2009).
86. Paulson KG, Carter JJ, Johnson LG et al. Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res. 70, 8388-8397 (2010).
87. Bain JR, Schisler JC, Takeuchi K, Newgard CB, Becker TC. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes 53, 2190-2194 (2004). (Pubitemid 39145570)
88. Bousarghin L, Touze A, Gaud G et al. Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Mol. Cancer Ther. 8, 357-365 (2009).
89. Haycox CL, Kim S, Fleckman P et al. Trichodysplasia spinulosa - a newly described folliculocentric viral infection in an immunocompromised host. J. Investig. Dermatol. Symp. Proc. 4, 268-271 (1999). (Pubitemid 30085818)
90. Osswald SS, Kulick KB, Tomaszewski MM, Sperling LC. Viral-associated trichodysplasia in a patient with lymphoma: a case report and review. J. Cutan. Pathol. 34, 721-725 (2007). (Pubitemid 47256249)
91. Chastain MA, Millikan LE. Pilomatrix dysplasia in an immunosuppressed patient. J. Am. Acad. Dermatol. 43, 118-122 (2000). (Pubitemid 30439724)
92. Sadler GM, Halbert AR, Smith N, Rogers M. Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Australas. J. Dermatol. 48, 110-114 (2007). (Pubitemid 46802052)
93. zur Hausen H. Novel human polyomaviruses - re-emergence of a well known virus family as possible human carcinogens. Int. J. Cancer 123, 247-250 (2008).
94. van der Meijden E, Kazem S, Burgers MM et al. Seroprevalence of Trichodysplasia spinulosa-associated Polyomavirus. Emerg. Infect. Dis 17, 1355-1363 (2011).
95. Sauvage V, Cheval J, Foulongne V et al. Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg. Infect. Dis 17, 1364-1370 (2011).
96. Viscidi RP, Clayman B. Serological cross reactivity between polyomavirus capsids. Adv. Exp. Med. Biol. 577, 73-84 (2006).
97. Multiple Sequence Alignment by ClustalW www.genome.jp/tools/clustalw
98. European Bioinformatics Institute phylogenic tree generator www.ebi.ac.uk/Tools/phylogeny